StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30210% above fair value
$237.31−0.79 (-0.33%)

Close on Nov 20, 2026Market cap $14.05BP/E –Yield –

Glaukos gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Glaukos's gross profit for the twelve months ending Sep 30, 2026 was $447.18M, up 23.8% year over year. For fiscal 2025 it was $282.76M, down 2.3% from the year before. Over ten years it grew 17.0% a year on average. The highest annual figure on record is $289.45M in fiscal 2024.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$282.76M-2.3%
FY2024Dec 31, 2024$289.45M+21.0%
FY2023Dec 31, 2023$239.14M+11.8%
FY2022Dec 31, 2022$213.88M-5.9%
FY2021Dec 31, 2021$227.38M+70.7%
FY2020Dec 31, 2020$133.24M-32.8%
FY2019Dec 31, 2019$198.40M+27.0%
FY2018Dec 31, 2018$156.20M+13.0%
FY2017Dec 31, 2017$138.20M+40.7%
FY2016Dec 31, 2016$98.22M+67.3%
FY2015Dec 31, 2015$58.71M+71.8%
FY2014Dec 31, 2014$34.17M+85.6%
FY2013Dec 31, 2013$18.41M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$179.87M+71.8%
Q2 FY2026Jun 30, 2026$151.59M+55.9%
Q1 FY2026Mar 31, 2026$117.23M+42.4%
Q4 FY2025Dec 31, 2025-$1.52M-102.0%
Q3 FY2025Sep 30, 2025$104.71M+41.3%
Q2 FY2025Jun 30, 2025$97.22M+32.9%
Q1 FY2025Mar 31, 2025$82.35M+26.0%
Q4 FY2024Dec 31, 2024$76.86M+21.1%
Q3 FY2024Sep 30, 2024$74.09M+24.4%
Q2 FY2024Jun 30, 2024$73.14M+21.3%
Q1 FY2024Mar 31, 2024$65.36M+17.1%
Q4 FY2023Dec 31, 2023$63.47M+17.5%
Q3 FY2023Sep 30, 2023$59.54M+9.4%
Q2 FY2023Jun 30, 2023$60.30M+9.9%
Q1 FY2023Mar 31, 2023$55.83M+10.3%
Q4 FY2022Dec 31, 2022$54.01M-4.2%
Q3 FY2022Sep 30, 2022$54.41M-8.3%
Q2 FY2022Jun 30, 2022$54.85M-9.1%
Q1 FY2022Mar 31, 2022$50.62M-1.4%
Q4 FY2021Dec 31, 2021$56.38M+5.1%
Q3 FY2021Sep 30, 2021$59.34M+26.5%
Q2 FY2021Jun 30, 2021$60.33M+510.1%
Q1 FY2021Mar 31, 2021$51.34M+125.1%
Q4 FY2020Dec 31, 2020$53.64M+7.4%
Q3 FY2020Sep 30, 2020$46.90M-7.7%
Q2 FY2020Jun 30, 2020$9.89M-80.5%
Q1 FY2020Mar 31, 2020$22.81M-51.4%
Q4 FY2019Dec 31, 2019$49.95M+6.4%
Q3 FY2019Sep 30, 2019$50.81M+34.1%
Q2 FY2019Jun 30, 2019$50.73M+37.1%
Q1 FY2019Mar 31, 2019$46.92M+36.6%
Q4 FY2018Dec 31, 2018$46.96M+26.8%
Q3 FY2018Sep 30, 2018$37.90M+9.2%
Q2 FY2018Jun 30, 2018$37.00M+3.5%
Q1 FY2018Mar 31, 2018$34.35M+11.8%
Q4 FY2017Dec 31, 2017$37.02M+30.5%
Q3 FY2017Sep 30, 2017$34.69M–
Q2 FY2017Jun 30, 2017$35.76M–
Q1 FY2017Mar 31, 2017$30.73M–
Q4 FY2016Dec 31, 2016$28.36M–

More Glaukos figures

See a number that looks wrong?